HomeNewsOpinionPolicy | Zero is not too far from 4.4; Repo at record low, inching towards CRR

Policy | Zero is not too far from 4.4; Repo at record low, inching towards CRR

A few more rounds of cuts, India may well be pushing close towards a theoretical possibility of zero percent policy rate regime

March 27, 2020 / 20:50 IST
Story continues below Advertisement
LIVE updates of the Reserve Bank of India (RBI)'s Monetary Policy Committee (MPC) decisions
LIVE updates of the Reserve Bank of India (RBI)'s Monetary Policy Committee (MPC) decisions

Reserve Bank of India (RBI) Governor Shaktikanta Das on March 27 delivered the second biggest single stroke repo rate cut — 75 basis points — in the central bank’s history, emphasising the devastation that the COVID-19 pandemic could cause across the broader economy.

Only four times before this has the repo — the rate at which banks borrow from the RBI — been slashed by a bigger margin — 100 basis points.

Story continues below Advertisement

Three of these cuts came in less than three months during October 2008 to January 2009 amid a piling rubble of the global financial crisis precipitated by the stunning collapse of Wall Street icon Lehman Brothers.

Between October 20, 2008, and January 5, 2009, then RBI Governor D Subbarao wielded the knife on the repo, slashing it by 350 basis points in four tranches — from 9 percent to 8 percent on October 20, 2008, from 8 percent to 7.5 percent November 3, 2008, from 7.5 percent to 6.5 percent on December 8, 2008, and from 6.5 percent to 5.5 percent on January 5, 2009.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show